Location History:
- Jerusalem, IT (1995)
- Jerusalem, IL (1998 - 2007)
Company Filing History:
Years Active: 1995-2007
Title: Andras Muhlrad: Innovator in Osteogenic Peptides
Introduction
Andras Muhlrad is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of synthetic peptides and pseudopeptides, particularly those with osteogenic activity. With a total of 4 patents, his work focuses on enhancing bone cell proliferation and formation.
Latest Patents
Muhlrad's latest patents include innovative synthetic peptides and pseudopeptides that have osteogenic activity. One of his notable inventions is a pharmaceutical composition that contains cyclic and synthetic pseudopeptide derivatives of osteogenic growth polypeptide (OGP). These compounds are designed to enhance bone cell proliferation and bone formation. His inventions aim to stimulate the formation of osteoblastic or fibroblastic cells, enhance bone formation in osteopenic conditions, repair fractures, heal wounds, and reverse bone loss in osteoporosis.
Career Highlights
Andras Muhlrad is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing the understanding and application of osteogenic peptides in medical treatments.
Collaborations
Muhlrad has collaborated with notable colleagues, including Michael Chorev and Itai A Bab, to further his research and development efforts in the field of osteogenic peptides.
Conclusion
Andras Muhlrad's innovative work in synthetic peptides and pseudopeptides has the potential to significantly impact the treatment of bone-related conditions. His contributions to the field exemplify the importance of research and development in advancing medical science.